Page 1

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington , DC 20549 FORM 10 - Q × QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 ( d ) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended July 31 , 2021 OR TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 ( d ) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number : 001-40483 ALZAMEND NEURO , INC . ( Exact name of registrant as specified in its charter ) Delaware ( State or other jurisdiction of incorporation or organization ) 3802 Spectrum Boulevard , Suite 112C , Tampa , FL ( Address of principal executive offices ) 33612 ( Zip Code ) 81-1822909 ( I.R.S. Employer Identification Number ) ( 844 ) 722-6303 ( Registrant's telephone number , including area code ) Securities registered under Section 12 ( b ) of the Act : Title of Each Class Common Stock , $ 0.0001 par value per share Securities registered under Section 12 ( g ) of the Act : None Trading Symbol ALZN Name of each exchange on which registered NASDAQ Capital Market Indicate by check mark whether the registrant ( 1 ) has filed all reports required to be filed by Section 13 or 15 ( d ) of the Securities Exchange Act of 1934 during the preceding 12 months ( or for such shorter period that the registrant was required to file such reports ) , and ( 2 ) has been subject to such filing requirements for the past 90 days . Yes x No " Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S - T during the preceding 12 months ( or for such shorter period that the registrant was required to submit such files ) . Yes x No " Indicate by check mark whether the registrant is a large accelerated filer , an accelerated filer , a non - accelerated filer , a smaller reporting company or an emerging growth company . See the definitions of " large accelerated filer , ” “ accelerated filer , ” “ smaller reporting company ” and “ emerging growth company " in Rule 12b - 2 of the Exchange Act : Large accelerated filer Non - accelerated filer X Emerging growth company X Accelerated filer " Smaller reporting company x If an emerging growth company , indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13 ( a ) of the Exchange Act . Indicate by check mark whether the registrant is a shell company ( as defined in Rule 12b - 2 of the Exchange Act ) . Yes ¨ No x As of September 13 , 2021 there were 86,887,858 shares of registrant's common stock , $ 0.0001 par value per share , outstanding . 1